IPAD-DB ID | C00037 |
Name | Eserine |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 2 1 N 3 O 2 |
Molecular Weight | 275.35g/mol |
IUPAC Name | [(3aR, 8bS)-3, 4, 8b-trimethyl-2, 3a-dihydro-1H-pyrrolo[2, 3-b]indol-7-yl] N-methylcarbamate |
InChI | InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6, 9, 13H, 7-8H2, 1-4H3, (H, 16, 19)/t13-, 15+/m1/s1 |
InChIKey | PIJVFDBKTWXHHD-HIFRSBDPSA-N |
Canonical SMILES | CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C |
PubChem CID | 5983 |
DrugBank Accession Number | - |
CAS Registry Number | 57-47-6 |
Molecular Weight(Computed by SwissADME) | 275.35 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 282.352 |
Density(Computed by ADMETlab 2.0) | 0.975 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 12 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 15 |
Flexibility(Computed by ADMETlab 2.0) | 0.2 |
Stero Centers(Computed by ADMETlab 2.0) | 2 |
LogS(Computed by ADMETlab 2.0) | -3.207 |
LogD(Computed by ADMETlab 2.0) | 1.756 |
logP(Computed by ADMETlab 2.0) | 1.616 |
TPSA(Computed by SwissADME) | 44.81 |
Hbond Acceptor(Computed by SwissADME) | 3 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.86 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |